Pelvic Mesh Information

There has been a great deal of interest and comment about the use of mesh as part of the surgical treatment of vaginal prolapse and urinary incontinence in New Zealand and Australia. A Senate Inquiry into the Number of women in Australia who have had transvaginal mesh implants and related matters reported its findings 28 March 2018. The report is available to download here; RANZCOG welcomed the report and the College's comment can be read here. This page provides a range of information relating to pelvic mesh in both countries, including RANZCOG statements and patient information, and RANZCOG’s submission to the Senate Inquiry.

Resources

New Zealand House of Representatives Report on Surgical Mesh

• RANZCOG Response to the New Zealand House of Representatives Report on Surgical Mesh

Senate Inquiry

• RANZCOG Submission to the Senate Inquiry into the number of women in Australia who have had transvaginal mesh implants and related matters
• Paper supporting RANZCOG Submission to Senate Inquiry on transvaginal mesh implant use and complications (Medibank)

RANZCOG Statements

• Polypropylene vaginal mesh implants for vaginal prolapse (C-Gyn 20)
• Midurerthral slings, Position statement (C-Gyn 32) 

Patient Information

• RANZCOG Patient Information Pamphlet: Stress Urinary Incontinence
• RANZCOG Patient Information Pamphlet: Pelvic Organ Prolapse
• RANZCOG Communiqué on the use of mesh  for the surgical treatment of vaginal prolapse and urinary incontinence (dated October 2017)
• RANZCOG Communiqué on Mid-urethral tapes for genuine stress incontinence (dated September 2015)
• Mesh removal in Australia information sheet 
• Mesh removal in  New Zealand information sheet

 

Follow us on social media

Facebook: @ranzcog
Twitter: @ranzcog
LinkedIn: ranzcog